This new, interactive course is made up of 11 modules illustrating the key pharmaceutical supply chain stakeholders and their functions as products move from the manufacturer to the customer.
Published in collaboration with Deloitte Consulting LLP, The Role of Distributors in the US Health Care Industry provides insights into the importance of wholesalers in driving efficiency and innovation...
High Price :0.00 | Low Price : 0.00
(Webinar Held: November 6) Overloaded inboxes, overflowing to-do lists, endless meetings and only one you. How could you possibly get everything done? You work late hours, bring work home and still the...
This report explores proposed drug importation policy — in general, and with an emphasis on federal legislation proposed since 2013.
Developed by HDMA’s eCommerce Task Force, this electronic data interchange (EDI) set supports the customary and established business and industry practices surrounding sales reporting.
PRICE : $0.00 - $495.00
This easy-to-use, tandem reference tool includes information and guidelines in support of two distinct business processes: controlled substance ordering and electronic contract re-submittals.
This paper further explains the process used to evaluate the numbering schema used by the pharmaceutical supply chain.
PRICE : $0.00 - $0.00
The Drug Supply Chain Security Act requires trading partners to pass Transaction Information, a Transaction History and the Transaction Statement when prescription drugs change ownership (as defined in...
HDA’s Guidelines for Bar Coding in the Pharmaceutical Supply Chain provides specifications for bar coding and labeling healthcare products.
From the point of receipt by a distributor to the point of delivery to a customer, the proper temperature of cold chain or frozen products must be maintained during product storage and transportation....
These guidelines educate trading partners across the healthcare supply chain in the processes used for the negotiation and administration of contracts, as well as the submission, validation and reconciliation...
PRICE : $0.00 - $75.00
This white paper provides a brief overview of the pharmaceutical supply chain, product supply issues and current processes that can result in product shortages.
Developed by HDMA’s Returns Task Force, this summary reports the volume and average dollar value of returned prescription and over-the-counter products processed by reverse logistics providers.
Developed by the HDMA Returns Task Force, this article identifies ways to reduce unsalable returns and reduce supply chain waste.